RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Joe Ramos to Phosphoproteins

This is a "connection" page, showing publications Joe Ramos has written about Phosphoproteins.
Connection Strength

3.580
  1. Sulzmaier F, Opoku-Ansah J, Ramos JW. Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases. 2012 Jul-Sep; 3(3):173-7.
    View in: PubMed
    Score: 0.384
  2. Gawecka JE, Geerts D, Koster J, Caliva MJ, Sulzmaier FJ, Opoku-Ansah J, Wada RK, Bachmann AS, Ramos JW. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer. 2012 Oct 01; 131(7):1556-68.
    View in: PubMed
    Score: 0.375
  3. Sulzmaier FJ, Valmiki MK, Nelson DA, Caliva MJ, Geerts D, Matter ML, White EP, Ramos JW. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene. 2012 Jul 26; 31(30):3547-60.
    View in: PubMed
    Score: 0.370
  4. Pastorino S, Renganathan H, Caliva MJ, Filbert EL, Opoku-Ansah J, Sulzmaier FJ, Gawecka JE, Werlen G, Shaw AS, Ramos JW. The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. FASEB J. 2010 Aug; 24(8):2818-28.
    View in: PubMed
    Score: 0.330
  5. Ramos JW, Townsend DA, Piarulli D, Kolata S, Light K, Hale G, Matzel LD. Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities. BMC Neurosci. 2009 Nov 16; 10:134.
    View in: PubMed
    Score: 0.322
  6. Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19837-42.
    View in: PubMed
    Score: 0.281
  7. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J. 2005 Sep 15; 390(Pt 3):729-35.
    View in: PubMed
    Score: 0.241
  8. Ramos JW. Cancer research center hotline: PEA-15 phosphoprotein: a potential cancer drug target. Hawaii Med J. 2005 Mar; 64(3):77-80.
    View in: PubMed
    Score: 0.232
  9. Vaidyanathan H, Ramos JW. RSK2 activity is regulated by its interaction with PEA-15. J Biol Chem. 2003 Aug 22; 278(34):32367-72.
    View in: PubMed
    Score: 0.206
  10. Ramos JW, Hughes PE, Renshaw MW, Schwartz MA, Formstecher E, Chneiweiss H, Ginsberg MH. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell. 2000 Sep; 11(9):2863-72.
    View in: PubMed
    Score: 0.170
  11. Ramos JW, Kojima TK, Hughes PE, Fenczik CA, Ginsberg MH. The death effector domain of PEA-15 is involved in its regulation of integrin activation. J Biol Chem. 1998 Dec 18; 273(51):33897-900.
    View in: PubMed
    Score: 0.151
  12. Greig FH, Kennedy S, Gibson G, Ramos JW, Nixon GF. PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia. J Am Heart Assoc. 2017 Sep 11; 6(9).
    View in: PubMed
    Score: 0.138
  13. Renault-Mihara F, Beuvon F, Iturrioz X, Canton B, De Bouard S, L?onard N, Mouhamad S, Sharif A, Ramos JW, Junier MP, Chneiweiss H. Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell. 2006 Dec; 17(12):5141-52.
    View in: PubMed
    Score: 0.065
  14. Sur R, Ramos JW. Vanishin is a novel ubiquitinylated death-effector domain protein that blocks ERK activation. Biochem J. 2005 Apr 15; 387(Pt 2):315-24.
    View in: PubMed
    Score: 0.058
  15. Chou FL, Hill JM, Hsieh JC, Pouyssegur J, Brunet A, Glading A, Uberall F, Ramos JW, Werner MH, Ginsberg MH. PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation. J Biol Chem. 2003 Dec 26; 278(52):52587-97.
    View in: PubMed
    Score: 0.052
  16. Hill JM, Vaidyanathan H, Ramos JW, Ginsberg MH, Werner MH. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 2002 Dec 02; 21(23):6494-504.
    View in: PubMed
    Score: 0.050
  17. Matter ML, Ginsberg MH, Ramos JW. Identification of cell signaling molecules by expression cloning. Sci STKE. 2001 Oct 09; 2001(103):pl9.
    View in: PubMed
    Score: 0.046
  18. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B, Nguyen XT, Barnier JV, Camonis J, Ginsberg MH, Chneiweiss H. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell. 2001 Aug; 1(2):239-50.
    View in: PubMed
    Score: 0.045
  19. Zhang Y, Redina O, Altshuller YM, Yamazaki M, Ramos J, Chneiweiss H, Kanaho Y, Frohman MA. Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem. 2000 Nov 10; 275(45):35224-32.
    View in: PubMed
    Score: 0.043
  20. Hunter I, Mascall KS, Ramos JW, Nixon GF. A phospholipase C?1-activated pathway regulates transcription in human vascular smooth muscle cells. Cardiovasc Res. 2011 Jun 01; 90(3):557-64.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support